Browsing: News

The VIV aesthetic clinic in Herzliya, its founder and former owner Dr. Tzachi Vider, a specialist surgeon in advanced aesthetic treatments and hyperhidrosis, Prof. Nahum Nesher,…

So who will fund the flood of new drugs and technologies that pharma companies are producing at such a rapid pace? This central question, faced by…

What is the state’s position on private health and drug insurance? Lior Barak, Deputy Director-General of the Supervision Division for HMOs and Supplemental Health Insurance at…

“We are living in an extraordinary era. Technology is soaring, medicine is advancing, and drugs are succeeding in saving lives, prolonging lives, curing people who once…

The concern of many in the insurance industry over a possible collapse of the drug insurance sector was voiced by Adv. Arik Ben Ezra, CEO of…

Against the backdrop of pessimism expressed by some participants regarding the future of drug insurance, Orit Kramer, Deputy CEO of Menora Mivtachim Insurance and Head of…

“The health basket includes not only life-saving and life-extending medications but also chronic drugs that cost enormous sums, burdening the basket and creating complexity in its…

“I am deeply concerned that the familiar drug insurance policy will be harmed unless changes are made. In addition, I suggested that the surgery section in…

“There must be a mechanism based on long-term savings and its yields. Pension funds achieved double-digit returns. There is no reason why long-term care policyholders should…

The accounting principles of IFRS 17, implemented from Q1 2025, continue to be embedded and impact insurers’ balance sheets. However, unfortunately, no guidelines have yet been…